WHO Warns Stronger Financing Needed to Combat Antimicrobial Resistance

World Health Organization officials have warned that global efforts to tackle Antimicrobial Resistance are being hindered by insufficient financing and weak implementation of national action plans.

According to health experts, while many countries have developed national AMR strategies, progress remains slow due to limited funding, weak monitoring systems and gaps in enforcement.

The report highlighted that regulations on antibiotic sales exist in several countries but are often poorly implemented, particularly in primary healthcare settings where most antibiotic prescriptions are issued.

Health authorities stressed the need to improve antibiotic stewardship programmes, strengthen education and training, and use digital tools to better monitor antibiotic use and sales.

The WHO also called for a stronger “One Health” approach that integrates human, animal, food and environmental health systems to address antimicrobial resistance more effectively. Officials noted that environmental surveillance remains one of the weakest areas in current AMR strategies.

The organisation emphasised that political leadership and long-term financial commitment are essential to strengthening infection prevention, surveillance systems and responsible antimicrobial use.

Experts further urged greater investment in diagnostics, preventive tools and antimicrobial research, while supporting local production and regulatory systems to ensure countries can safely access and manage essential medicines.

The WHO warned that conflicts, fragile healthcare systems and climate change are accelerating the spread of antimicrobial resistance, making global cooperation and accountability increasingly important to protect future generations.